Profit

Biocon: Next big trigger?

PUBLISHED ON: June 19, 2009 | Duration: 10 min, 19 sec

facebooktwitteremailkoo
loading..
Kiran Mazumdar Shaw, CMD of Biocon, said the company begins Phase 3 trials of oral insulin drug.
ALSO WATCH
Rakesh Jhunjhunwala's Wife Loses Rs 800 Crore As Her Biggest Stock Bet Tanks

................................ Advertisement ................................

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com